People
Kristian Doyle earned his PhD from Oregon Health & Science University in 2007, developing novel therapeutics for stroke in the laboratory of Mary Stenzel-Poore. He then trained as a Postdoctoral Scholar at Stanford University under the mentorship of Marion Buckwalter, researching the role of TGFbeta signaling after stroke and developing a model of post-stroke dementia. Kristian Doyle started as an Assistant Professor at the University of Arizona in 2013.
Jen Frye received her Bachelor’s Degree in Ecology and Evolutionary Biology from The University of Arizona. In the Doyle lab, Jen employs her extensive research background to investigate the inflammatory response to stroke in humans as well as different rodent models. In her spare time, Jen enjoys football, wakeboarding, and spending time with her family.
Boaz is an undergraduate student at the University of Arizona studying physiology. He joined the Doyle lab in the summer of 2021 through the SIMI research program. He is currently researching the effects of stroke on Alzheimer's disease. His hobbies include going out on an evening run and working out with his neighbor in his patio gym.
Analisa received her Bachelor’s of Science in Biology from Arizona State University in 2022. She also holds an AAS in Medical Laboratory Technology. During her undergraduate research at Banner Sun Health Research Institute’s Brain and Body Donation Program Analisa became interested in early in vivo differentiation of dementia in human patients using ‘omics tools. In her work with the Doyle Lab Analisa is pursuing her understanding of the inflammatory response to stroke and other neurodegenerative diseases in human and murine models using transcriptomic tools. Outside of the lab Analisa enjoys spending time with her family including her two dogs, Pilates, impressionist jazz, urban forestry and knitting.
Susie Whitman holds a Bachelor of Science degree in Chemistry and a Master of Science degree in Toxicology from the University of Arizona. Not only was she raised in Tucson, AZ, but both her sons were raised in Tucson and currently attend the University of Arizona as well. Throughout her career, she has contributed her scientific expertise to various labs at UA, focusing on areas such as children's leukemia, heart disease, the bone microenvironment, and currently, stroke research with the Doyle lab. In the Doyle lab, Susie's primary focus is on identifying biomarkers associated with stroke in both human and rodent models. In her spare time, she enjoys outdoor activities, reading a good mystery novel, and spending time with her family
Jennifer relocated to Tucson, Arizona, in June of 2021 from Norman, Oklahoma, where she ran her own business. Jennifer has a Master's in Library and Information Science from the University of Arizona. Her area of interest is data management and preservation but does enjoy a good book and discussion. When she is not working, she enjoys painting and traveling with her husband and children.
Esther is an undergraduate student at the University of Arizona, majoring in Physiology and Medical Sciences. Esther joined the Doyle lab in the Fall of 2023 and continued through UBRP in the summer of 2024. She is currently researching the various immunological events that occur in stroke and Alzheimer's disease. Outside of research, she enjoys playing tennis, attending music festivals, and spending time with my friends.
Danielle Becktel received her BS in Biology from Butler University in 2016, and her PhD in Molecular Medicine – Cell Biology, with a minor in Cancer Biology, at the University of Arizona in 2023. In 2018, she joined the Doyle lab to investigate the chronic production of degradative enzymes in the area of liquefaction following stroke. In her spare time, Danielle enjoys hiking, camping, and playing board games with friends.
Sangeetha holds a Ph.D. in Biochemistry with research experience in cancer chemoprevention and innate immunity against streptococcal infections. In the Doyle Lab, she investigates the role of adaptive immunity in ischemic stroke. Her research aims to contribute to the development of clinically effective therapeutics by understanding the pathophysiology of stroke, including the immunological, molecular, and cellular changes.